The Valley Desk

NCT03381729 · Interventional trial

Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy

Overall registry status Terminated

Phase 1

Conditions Spinal Muscular Atrophy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov